New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:1/10/2019
Start Date:November 15, 2017
End Date:December 2020
Contact:Matthew W Urban, Ph.D.
Email:Urban.Matthew@mayo.edu
Phone:507-538-1522

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

New Technologies to Determine Carotid Plaque Vulnerability: A Pilot Study to Assess Contrast-Enhanced Ultrasound (CEUS) and Shear Wave Elastography (SWE) in Patients With Significant Carotid Plaques

The researchers are trying to determine if the characterization of "vulnerable" carotid
artery plaques can be accomplished with ultrasound-based methods that look for vessels in the
plaque and measure the plaque stiffness.

All participants will receive a one time Carotid contrast-enhanced Ultrasound (CEUS)
examination that may take 30-60 minutes. Follow up calls will be made to the Participants at
6, 12 ,24 and 36 months to ask about occurrence of major adverse cardiovascular events.

Inclusion Criteria:

- Subject has carotid plaque with > 50% stenosis

- Subject is able to understand the study procedure and provide informed consent

Exclusion Criteria:

- Subject is pregnant or breast feeding

- Subject is unable to provide informed consent

- Subject has contraindication to the use of the Lumason contrast agent.
We found this trial at
1
site
Mayo Clinic Rochester
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Principal Investigator: Matthew W Urban, Ph.D.
Phone: 507-538-1522
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials